Viruses and asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 10, 1998, Pages 922-932

  Johnston, S L ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ASTHMA; COMORBIDITY; CORONAVIRUS; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFLUENZA VIRUS; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; TREATMENT PLANNING; UPPER RESPIRATORY TRACT INFECTION; VIRUS DETECTION; VIRUS PNEUMONIA;

EID: 0031754941     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03792.x     Document Type: Review

References (90)

1. Chauhan AJ, Johnson A-WBR, Xic P, et al. Virus infections in infants and children admitted to hospital with acute respiratory illness (submitted).
2. Johnston SL, Holgate ST. Epidemiology of viral respiratory tract infections. In: Myint S, Taylor-Robinson D, editors. Viral and other infections of the human respiratory tract. London: Chapman & Hall, 1996:1-38.
3. Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy 1992;22:325-36.
4. Johnston SL, Sanderson G, Pattemore PK, et al. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol 1993;31:111-17.
5. Ireland DC, Kent J, Nicholson KG. Improved detection of rhinovirus in nasal and throat swabs by semi-nested RT-PCR. J Med Virol 1993;40:96-101.
6. Myint S, Johnston S, Sanderson G, Simpson H. Evaluation of nested polymerase chain methods for the detection of human coronaviruses 229E and OC43. Mol Cell Probes 1995;8:357-64.
7. Freymuth F, Vabret A, Galateau-Salle F, et al. Detection of respiratory syncytial virus, parainfluenza virus 3, adenovirus and rhinovirus sequences in respiratory tract of infants by polymerase chain reaction and hybridization. Clin Diagn Virol 1997;8:31-40.
8. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11-year-old children. BMJ 1995;310:1225-8.
9. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-6.
10. Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time trend analysis. Am J Respir Crit Care Med 1996;154:654-60.
11. Campbell MJ, Holgate ST, Johnston SE. Trends in asthma mortality. BMJ 1998;315:1012.
12. Durham S. ABC of allergies. Summer hay fever. BMJ 1998;316:843-5.
13. Wilson NW, Silverman M. Treatment of acute, episodic asthma in pre-schoolchildren using intermittent high dose inhaled steroids at home. Arch Dis Child 1990; 65:407-10.
14. Stick SM, Burton PR, Clough JB, et al. The effects of inhaled beclomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infants. Arch Dis Child 1995;73:327-32.
15. Doull IJM, Lampe FC, Smith S, Schreiber J, Freezer NJ, Holgate ST. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997;315:858-62.
16. Johnston SL. Problems and prospects of developing effective therapy for common cold viruses. Trends Microbiol 1997;5:58-63.
17. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995;96:549-57.
18. Zhu Z, Tang W, Ray A, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. J Clin Invest 1996;97:421-30.
19. Bates PJ, Sanderson G, Holgate ST, Johnston SL. A comparison of RT-PCR, in situ hybridisation and in situ RT-PCR for the detection of rhinovirus infection in paraffin sections. J Virol Methods 1997;67:153-60.
20. Johnston SL, Papi A, Bates PJ, Mastronarde JG, Monick MM, Hunninghake GW. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 1998;160:6172-81.
21. Papadopoulos NG, Sanderson G, Hunter J, Johnston SL. Rhinoviruses replicate effectively at lower airway temperatures (submitted).
22. Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997;155:1159-61.
23. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995;151:879-86.
24. Bates PJ, Bardin PG, Fraenkel DJ, Sanderson G, Holgate ST, Johnston SL. Localisation of rhinovirus in the bronchial epithelium of experimentally infected human volunteers. Am J Respir Crit Care Med 1998;157:A25.
25. Teran LM, Johnston SL, Schröder J, Church MK. Holgate ST. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997;155:1362-6.
26. Grunberg K, Timmers MC, Smits HH, et al. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 1997;27:36-45.
27. Johnston SL, Papi A, Monick MM, Hunninghake GW. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J Infect Dis 1997; 175:323-9.
28. Gern JE, Dick EC, Lee WM, et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 1996;156:621-7.
29. Grunberg K, Smits HH, Timmers MC, et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum of asthmatic subjects. Am J Respir Crit Care Med 1997;156:609-16.
30. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation and segmental allergen bronchoprovocation in allergic subjects. J Clin Invest 1994;94:2200-8.
31. Teran L, Seminario MC, Shute JK, et al. RANTES, MIP-1α and the eosinophil product MBP are released into upper respiratory secretions during virus-induced asthma exacerbations in children. J Infect Dis 1998 (in press).
32. Trigg CJ, Nickolson KG, Wang JH, et al. Bronchial inflammation and the common cold: a comparison of atopic and non-atopic individuals. Clin Exp Allergy 1996; 26:665-76.
33. Romagnani S. Induction of Th1 and Th2 responses. Immunol Today 1992;13:379-81.
34. Coyle AJ, Erard F, Bertrand C, Walti S, Pircher H, Le Gros G. Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med 1995;181:1229-33.
35. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur J Immunol 1997;27:3341-9.
36. Gern JE, Galagan DM, Jarjour NN, Kelly EAB, Busse WW. Cytokine and rhinovirus 16 (RV16) RNA in the lower airway of experimentally infected subjects. Am J Respir Crit Care Med 1996;153:A17.
37. Roman M, Calhoun WJ, Hinton KL, et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997;156:190-5.
38. Hussell T, Khan U, Openshaw PJM. IL-12 treatment attenuates Th2 and B cell responses but does not improve vaccine-enhanced lung illness. J Immunol 1997;159:328-34.
39. Terajima M, Yamaha M, Sekizawa K, et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. Am J Physiol 1997;273:L749-59.
40. Sethi SK, Bianco A, Allen JT, Knight RA, Spiteri MA. Interferon-gamma (IFN-γ) down-regulates the rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells. Clin Exp Immunol 1997;110:362-9.
41. Papi A, Johnston SL. Rhinovirus infection induces expression of its own receptor ICAM-1 via increased NFκB mediated transcription. 1998 (submitted).
42. Sharon RF, Grunberg K, van Krieken JHJM, Sterk PJ. Rhinovirus (RV-16) infection enhances ICAM-1 expression in bronchial mucosal biopsies of mildly asthmatic subjects, regardless of inhaled steroid treatment. Am J Respir Crit Care Med 1998;157:A22.
43. Stark JM, Godding V, Sedgewick JB, Busse WW. Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1. J Immunol 1996;156:4774-82.
44. Arnold R, Konig W. ICAM-1 expression and low-molecular-weight G-protein activation of human bronchial epithelial cells (A549) infected with RSV. J Leukoc Biol 1996;60:766-71.
45. Becker S, Reed W, Henderson FW, Noah TL. RSV infection of human airway epithelial cells causes production of the chemokine RANTES. Am J Physiol 1997; 272:L512-20.
46. Matsukura S, Kokubu F, Tomita T, et al. Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol 1998; 18:255-64.
47. Coyle AJ, Tyers M, Church D, et al. Upregulation of chemokine receptors on bronchial epithelial cells in vitro following rhinovirus 14 infection. Am J Respir Crit Care Med 1998;157: A200.
48. Stellato C, Collins P, Ponath PD, et al. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 1997;99:926-36.
49. Cook DN, Beck MA, Coffman TM, et al. Requirement of MIP1α for an inflammatory response to viral infection. Science 1995;269:1583-5.
50. Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects following upper respiratory tract infection. Am Rev Respir Dis 1976;113:523-7.
51. Aquilina AT, Hall WJ, Douglas RG, Utell MJ. Airway reactivity in subjects with viral upper respiratory tract infections: the effects of exercise and cold air. Am Rev Respir Dis 1980;122:3-10.
52. Folkerts G, Nijkamp FP. Virus induced airway hyperresponsiveness. Role of inflammatory cells and mediators. Am J Respir Crit Care Med 1995;151:1666-74.
53. Gern JE, Calhoun W, Swenson C, Shen G, Busse WW. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 1997;155:1872-6.
54. Skoner DP, Doyle WJ, Seroky J, Fireman P. Lower airway responses to influenza A virus in healthy allergic and nonallergic subjects. Am J Respir Crit Care Med 1996;154:661-4.
55. Johnston SL. Bronchial hyperresponsiveness and cytokines in virus-induced asthma exacerbations. Clin Exp Allergy 1997;27:7-9.
56. Killingsworth CR, Robinson NE, Adams T, Maes RK, Berney C, Rozanski E. Cholinergic reactivity of tracheal smooth muscle after infection with feline herpesvirus-I. J Appl Physiol 1990;69:1953-60.
57. Buckner CK, Songsiridej V, Dick EC, Busse WW. In vivo and in vitro studies of the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am Rev Respir Dis 1985;132:305-10.
58. Fryer AD, Jacoby DB. Parainfluenza virus infection damages inhibitory M: muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1991;102:267-71.
59. Sorkness R, Clough J, Castelman W, Lemanske R. Virus induced airway obstruction and parasympathetic hyperresponsiveness in adult rats. Am Rev Respir Dis 1994;150:28-34.
60. 2 muscarinic receptor function in parainfluenza virus-infected guinea-pigs. Br J Pharmacol 1994;112:588-94.
61. 2 receptor. J Clin Invest 1993;91: 1314-18.
62. 2 muscarinic receptor function. Am J Physiol 1997;273:L9344.
63. 2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest 1997;100:2254-62.
64. 2 muscarinic receptors in antigen challenged guinea-pigs is restored by heparin and poly-L-glulamate. J Clin Invest 1992;90:2292-8.
65. Ladenius ARC, Folkerts G, van der Linde HJ, Nijkamp FP. Potentiation by viral respiratory infection of ovalbumin-induced guinea pig tracheal hyperresponsiveness: role for tachykinins. Br J Pharmacol 1995;115:1048-52.
66. Dusser DJ, Jacoby DB, Djokic TD, Rubinstein I, Borson DB, Nadel JA. Virus induces airway hyperresponsiveness to tachykinins: role of neutral endopeptidase. J Appl Physiol 1989;67:1504-11.
67. De Gouw HWFM, Grunberg K, Schot R, Kroes ACM, Dick EC, Sterk PJ. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 1998;11:126-32.
68. Folkerts G, van der Linde HJ, Nijkamp FP. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J Clin Invest 1995;95:26-30.
69. Sanders SP, Siekierski ES, Porter JD, Richards SM, Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 1998;72:934-42.
70. Einarsson O, Geha GP, Zhu Z, Landry M, Elias JA. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest 1996;97:915-24.
71. Tang W, Geba GP, Zheng T, et al. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling and airways obstruction. J Clin Invest 1996;98:2845-53.
72. Dumitrascu D, Sanderson G, Mukaida N, Matsushima K, Holgate ST, Johnston SL. IL-8 and AP-1 and κB-like sites are necessary for rhinovirus induction of IL-8 promoter activity in A549 cells. J Allergy Clin Immunol 1997;99:5403.
73. Bitko V, Velazquez A, Yang L, Yang Y-C, Barik S. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-κB and is inhibited by sodium salicylate and aspirin. Virology 1997;232:369-78.
74. Fiedler MA, Wernke-Dollries K, Stark JM. Inhibition of viral replication reverses respiratory syncytial virus-induced NF-κB activation and interleukin-8 gene expression in A549 cells. J Virol 1996;70:9079-82.
75. Jamaluddin M, Garofalo R, Ogra PL, Brasier AR. Inducible transcriptional regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection of pulmonary epithelial cells. J Virol 1996;70:1554-63.
76. Mastronarde JG, He B, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-κB and NF-IL-6. J Infect Dis 1996;174:262-7.
77. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994;265:956-9.
78. Duff AL, Pomeranz, ES, Gelber LE, et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 1993;92:535-40.
79. Schwarze J, Hamelmann E, Bradley KL, Takeda K, Gelfand EW. Respiratory syncytial virus results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 1997;100:226-33.
80. O'Donnell DR, Openshaw PJM. Anaphylactic sensitization to aeroantigen during respiratory virus infection. Clin Exp Allergy 1998 (in press).
81. Sigurs N, Bjarnason R, Bergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995;95:500.
82. Alwan WH, Kozlowska WJ, Openshaw PJM. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med 1994;179:81-9.
83. Shaheen SO. Discovering the causes of atopy. BMJ 1997;314:987-8.
84. Strachan DP. Hay fever, hygiene and household size. BMJ 1989;299:1259-60.
85. Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet 1996;347:1792-6.
86. Matricardi PM, Rosmini F, Ferrigno L. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997;314:999-1003.
87. Shirakawa T, Enomoto T, Shimazu S-I, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-9.
88. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998;187:561-9.
89. Wang CC, Rook GAW. Inhibition of an established response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology 1998;93:307-13.
90. Alm JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 1997;350:400-3.